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Abstract. 
 
A small GTPase Ran is a key regulator for 
active nuclear transport. In immunoblotting analysis, a 
monoclonal antibody against recombinant human Ran, 
designated ARAN1, was found to recognize an epitope 
in the COOH-terminal domain of Ran. In a solution 
binding assay, ARAN1 recognized Ran when com-
 
plexed with importin 
 
b
 
, transportin, and CAS, but not 
the Ran-GTP or the Ran-GDP alone, indicating that 
the COOH-terminal domain of Ran is exposed via its 
interaction with importin 
 
b
 
Ðrelated proteins. In addi-
tion, ARAN1 suppressed the binding of RanBP1 to the 
RanÐimportin 
 
b
 
 complex. When injected into the nu-
cleus of BHK cells, ARAN1 was rapidly exported 
to the cytoplasm, indicating that the RanÐimportin 
 
b
 
Ðrelated protein complex is exported as a complex 
from the nucleus to the cytoplasm in living cells. More-
over, ARAN1, when injected into the cultured cells in-
duces the accumulation of endogenous Ran in the
cytoplasm and prevents the nuclear import of SV-40
T-antigen nuclear localization signal substrates. From 
these findings, we propose that the binding of RanBP1 
to the RanÐimportin 
 
b
 
 complex is required for the dis-
sociation of the complex in the cytoplasm and that the 
released Ran is recycled to the nucleus, which is essen-
tial for the nuclear protein transport.
Key words: nuclear protein import ¥ Ran ¥ mono-
clonal antibody ¥ importin ¥ microinjection
 
T
 
HE
 
 intracellular transport of macromolecules be-
tween the nucleus and the cytoplasm takes place
 
through the nuclear pore complexes (NPCs)
 
1
 
 which
permit the passive diffusion of molecules smaller than 20Ð
40 kD and also support an active and receptor-mediated
transport. The active protein import pathway which has
been studied most intensively is mediated by a basic-type
nuclear localization signal (NLS) which contains a short
amino acid stretch rich in basic amino acids. The basic-
type NLS of the import substrate binds to the hetero-
 
dimeric importin 
 
a
 
/
 
b
 
 to form a nuclear pore-targeting com-
plex. Importin 
 
a
 
 provides the NLS-binding site, whereas
importin 
 
b
 
 accounts for the targeting of the complex to the
NPC (for reviews see Grlich and Mattaj, 1996; Koepp
and Silver, 1996; Grlich, 1997; Nigg, 1997; Yoneda, 1997).
In addition to the basic-type NLS mediated import path-
way, it is known that the import of heterogeneous nuclear
RNA-binding protein A1 (hnRNP A1) is mediated by a
signal comprised of 38 amino acids, which is referred to as
M9, and which is rich in glycine and aromatic residues. M9
 
directly binds to an importin 
 
b
 
Ðrelated transport factor,
transportin (Nakielny et al., 1996; Pollard et al., 1996). It has
also been demonstrated that the nuclear export of some
proteins depend on nuclear export signal (NES), which is
rich in hydrophobic residues (for review see Nakielny and
Dreyfuss, 1997). Nuclear export of proteins containing NES
is mediated by an importin 
 
b
 
Ðrelated export receptor, CRM1
(Fornerod et al., 1997b; Fukuda et al., 1997; Ossareh et al.,
1997; Stade et al., 1997). Although the export signal of im-
portin 
 
a
 
 has not been identified, its export is also mediated
by another importin 
 
b
 
Ðrelated export receptor, cellular apop-
tosis susceptibility gene (CAS) (Kutay et al., 1997). These
 
transport factors, importin 
 
b
 
, transportin, CAS, and CRM1
constitute a protein superfamily which has a Ran-GTPÐ
binding motif (Fornerod et al., 1997a; Grlich et al., 1997).
A small GTPase Ran is known to be essential for the ac-
tive transport pathways including the import of the basic-
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type NLS and M9 containing proteins or snRNPs, or the
export of importin 
 
a
 
, NES-containing proteins, tRNA,
UsnRNA, and several mRNAs (Melchior et al., 1993a;
Moore and Blobel, 1993; Koepp et al., 1996; Nakielny et
al., 1996; Izaurralde et al., 1997; Kutay et al., 1997; Rich-
ards et al., 1997; for reviews see Avis and Clarke, 1996;
Koepp and Silver, 1996; Grlich, 1997; Goldfarb, 1997).
Ran is predominantly, but not exclusively, a nuclear pro-
tein (Bischoff and Ponstingl, 1991a). The Ran GTPase cy-
cle is regulated by the GDPÐGTP exchange factor, RCC1,
which charges Ran with GTP (Bischoff and Ponstingl,
1991b), the GTPase-activating protein, RanGAP1, which
converts Ran-GTP into Ran-GDP (Bischoff et al., 1994;
Becker et al., 1995; Corbett et al., 1995), and RanBP1 (or
RanBP2) whose binding to Ran-GTP further stimulates
the GTPase-activating activity of RanGAP1 (Coutavas et
al., 1993; Bischoff et al., 1995; Richards et al., 1995). RCC1
is a chromatin-associated nuclear protein (Ohtsubo et al.,
1989), whereas RanGAP1 and its coactivator, RanBP1, are
exclusively cytoplasmic, and RanBP2 is located on the cy-
toplasmic fibrils of the NPC (Hopper et al., 1990; Melchior
et al., 1993b; Bischoff et al., 1994, 1995; Wu et al., 1995;
Yokoyama et al., 1995; Matunis et al., 1996; Richards et al.,
1996; Mahajan et al., 1997). Because of this asymmetric dis-
tribution of RCC1, RanGAP1, and RanBP1/RanBP2, it
has been predicted that a steep Ran-GTP gradient across
the nuclear envelope exists (very low levels of cytoplasmic
Ran-GTP and high levels inside the nucleus). 
 In the case of nuclear import of proteins which contain
the basic-type classical NLS, it has been proposed that
Ran is involved in several different steps in the process. At
least a portion of the energy required for translocation
through the NPC is supplied via GTP hydrolysis by Ran
(Melchior et al., 1993a), although other GTPases may also
be involved (Sweet and Gerace, 1996). In addition, nuclear
Ran-GTP functions to terminate the import reaction. Af-
ter the translocation of the trimeric complex, which is
comprised of importin 
 
a
 
/
 
b
 
 and a karyophile with the classi-
cal NLS, through the nuclear envelope, the direct binding of
nuclear Ran-GTP to importin 
 
b 
 
causes the dissociation of
the trimeric complex thus releasing the cargo (Rexach and
Blobel, 1995; Grlich et al., 1996; Moroianu et al., 1996). In
the same manner, transportin binds to its cargo only in the
absence of Ran-GTP, i.e., in the cytoplasm and releases it
in the nucleus. For the next rounds of nuclear import, im-
portin 
 
b
 
 and transportin are required to return to the cyto-
plasm and dissociate from Ran-GTP. In contrast, the binding
of the export receptors such as CRM1 and CAS to their car-
gos is enhanced by the simultaneous binding of Ran-GTP,
which occurs in the nucleus. The trimeric cargo-export re-
ceptorÐRan-GTP complex is then transferred to the cyto-
plasm. Thus, the binding of Ran-GTP to importin 
 
b
 
Ðrelated
transport factors regulates their interaction with cargos or
adapter molecules. Therefore, it has been suggested that this
Ran-GTP concentration gradient is a critical determinant in
the directionality of nucleocytoplasmic transport, ensuring
that the transport factors carry their cargoes unidirectionally
(Grlich et al., 1996, 1997; Izaurralde et al., 1997).
It is also noteworthy that the Ran-GTPÐimportin 
 
b
 
complex is very stable and resistant to the Ran GTPase ac-
tivating activity of RanGAP1 (Floer and Blobel, 1996).
Biochemical analyses have suggested that RanBP1 di-
 
rectly promotes the dissociation of Ran-GTP from impor-
tin 
 
b
 
, CAS, and transportin (Bischoff and Grlich, 1997;
Lounsbury et al., 1997). Nuclear injection of RanGAP1
significantly inhibited the export of injected importin 
 
a
 
and 
 
b
 
, transportin, and NES-containing proteins in 
 
Xeno-
pus laevis 
 
oocyte (Izaurralde et al., 1997). As a result, it
has been proposed that the importin 
 
b
 
Ðrelated transport
factors are probably exported to the cytoplasm as com-
plexes with Ran-GTP, and that these complexes dissociate
and Ran is then converted to the GDP-bound form by
RanGAP1 in conjunction with RanBP1 in the cytoplasm
(Bischoff and Grlich, 1997; Izaurralde et al., 1997). How-
ever, direct in vivo evidence for this proposal is currently
lacking.
 Unlike other small GTPases, Ran has negatively charged
amino acid residues at the COOH terminus instead of con-
sensus sequences for lipid modification. To better under-
stand the biological significance of the COOH-terminal do-
main, the COOH terminus-deleted mutant Ran, referred to
as 
 
D
 
DE-Ran, has been used (Lounsbury et al., 1994, 1996a,b;
Ren et al., 1995; Richards et al., 1995; Carey et al., 1996; Chi
et al., 1997). This mutant is capable of supporting the nu-
clear import of basic-type NLS-containing substrates in
digitonin-permeabilized semi-intact cells, whereas the 
 
D
 
DE-
Ran, which is expressed in cultured cells has a dominant-
negative phenotype for both nuclear protein import and
RNA export (Ren et al., 1995; Richards et al., 1995; Carey et
al., 1996). This mutant protein has a lower affinity for
RanBP1 than the wild-type (wt) Ran and binds to importin
 
b
 
 with higher affinity than wild-type Ran in an overlay assay
(Richards et al., 1995; Lounsbury et al., 1996b). These re-
sults suggest that the deletion of the COOH-terminal por-
tion of Ran may be the cause of the defect in the Ran GTP-
ase cycle. However, the issue of how the COOH-terminal
domain is involved in the nucleocytoplasmic transport or the
Ran GTPase cycle is not known with certainty, since the de-
letion in COOH-terminal domain may cause drastic confor-
mational changes in Ran. 
 In this study, in order to identify functional domains of
Ran including the COOH-terminal domain, we produced
anti-Ran monoclonal antibodies (mAbs). By using one of
the anti-Ran mAbs, we provide evidence that the COOH-
terminal domain of Ran is not exposed to the surface of
the molecule until Ran interacts with importin 
 
b
 
 or impor-
tin 
 
b
 
Ðrelated transport factors, CAS and transportin. This
observation suggests that the exposed COOH-terminal acidic
sequence of Ran may be essential for the binding of RanBP1
to the Ran-GTP complexed with importin 
 
b
 
Ðrelated trans-
port factors. Furthermore, we show in vivo evidence that
Ran/importin
 
 b
 
 can be exported in the form of a complex
from the nucleus to the cytoplasm. Our results indicate
that the binding of RanBP1 to the Ran/importin 
 
b
 
 com-
plex in the cytoplasm, which appears to be blocked by in-
jected mAb, is essential for the recycling of Ran and nu-
clear protein import.
 
Materials and Methods
 
Production of mAbs
 
mAbs were obtained essentially according to the procedure of Khler and
Milstein (1975). 50 
 
m
 
g of denatured recombinant human Ran was initially 
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intraperitoneally administered with FreundÕs complete adjuvant to a
16-wk-old BDF1 mouse (Japan SLC), followed by three subsequent injec-
tions at 3-wk intervals with the same dose in FreundÕs incomplete adju-
vant. 1 mo after the fourth injection, the mouse was given a booster injec-
tion of the same dose. 4 d later, spleen cells isolated from the mouse were
fused with the mouse myeloma cell line P3U1 using standard methods.
Screening was performed by ELISA and immunoblotting using the re-
combinant human Ran. Ran-specific mAbs were typed by using mouse
monoclonal antibody isotyping kit (Amersham). Ascites fluid was pro-
duced from a BDF1 
 
3 
 
BALB/3T3 mouse (Japan SLC) which had been im-
planted with the hybridoma. The IgG fraction was obtained by precipita-
tion with 50% saturated ammonium sulfate followed by chromatography
on a protein A affinity column.
 
Antibodies
 
Rabbit anti-Ran polyclonal antibodies were produced as described previ-
ously (Sekimoto et al., 1996). Chromatographically purified normal mouse
IgG was purchased from Zymed. Rabbit antiÐimportin 
 
b
 
 polyclonal anti-
bodies were prepared as described previously (Kose et al., 1997). Mouse
antiÐhuman CAS monoclonal antibody and mouse antiÐhuman transpor-
tin monoclonal antibody were purchased from Transduction Laboratories. 
 
Expression and Purification of Recombinant Proteins
 
Expression and purification of recombinant importin 
 
b
 
 were performed
as described previously (Kose et al., 1997). The human CAS gene was am-
plified from a HeLa cDNA library via the polymerase chain reaction
(PCR) using the synthetic oligonucleotide primers, 5
 
9
 
-TTTTTTGGA-
TCCATGGAACTCAGCGATGCAAATCTGCAA-3
 
9 
 
and 5
 
9
 
-TTTTTT-
CTCGAGTTAAAGCAGTGTCACACTGGCTGCCTG-3
 
9
 
. The PCR
product was inserted into BamHI and XhoI sites of pGEX-6P-2/hGFP vec-
tor, which was an expression vector of glutathione-S-transferase (GST)-
fused green fluorescent protein (containing the S65A/Y145F mutation)
(hGFP). This construct was transformed to express the recombinant
GSTÐhGFP-CAS fusion protein in 
 
Escherichia coli
 
 strain BL21. The ex-
pressed GSTÐhGFP-CAS fusion protein was purified on glutathioneÐ
Sepharose (Pharmacia Biotech). After the digestion of GST portion with
PreScission Protease (Pharmacia Biotech), hGFPÐCAS protein was puri-
fied by ion-exchange chromatography on Hi-TrapQ (Pharmacia Biotech,
Inc.), and then was dialyzed against 20 mM Hepes, pH 7.3, 110 mM potas-
sium acetate, 2 mM DTT, and 1 
 
m
 
g/ml each of aprotinin, leupeptin, and
pepstatin.
 Human transportin/karyopherin 
 
b
 
2 gene (Pollard et al., 1996; Bonifaci
et al., 1997) was amplified from HeLa cell cDNA library by the PCR using
the synthetic oligonucleotide primers (5
 
9
 
-CTCAGCGGATCCATGGAG-
TATGAGTGGAAACCTGAC-3
 
9
 
 and 5
 
9
 
-CTCAGCGGTACCTTAAAC-
ACCATAAAAAGCTGCAAG-3
 
9
 
). The PCR product was inserted into
the BamHI and KpnI sites of a modified pGEX-6P-3 (Pharmacia) and veri-
fied by DNA sequencing. Recombinant GST-transportin was expressed
and purified as described for hGFPÐCAS.
 
 
E
 
.
 
 coli
 
 strains expressing wild-type Ran were prepared as described pre-
viously (Sekimoto et al., 1996). Mutation (Q69L) within Ran was created
using QuikChange site-directed mutagenesis kit (Strategene). RanQ69L
fragment was inserted into NcoI and BamHI sites of pET3d. Recombinant
RanQ69L protein was expressed in 
 
E
 
.
 
 coli
 
 and purified in the same man-
ner as wild-type Ran. Recombinant wild-type and Q69L Ran were ex-
pressed, purified, and then charged with GTP or GDP according to the
method of Bischoff and Ponstingl (1995) and Melchior et al. (1995) with
slight modifications. In brief, expression was induced by addition of 1 mM
isopropyl-
 
b
 
 
 
D
 
-thiogalactopyranoside (IPTG) and incubation for 14 h at 20
 
8
 
C.
The 
 
E
 
.
 
 coli
 
 cells were lysed in buffer C (50 mM Tris-HCl, pH 8.0, 75 mM
NaCl, 1 mM MgCl
 
2
 
, 0.1 mM PMSF, 1 mM DTT, 1 mg/ml each of aprotinin,
leupeptin, and pepstatin) by freeze-thaw. The clarified lysates were ap-
plied to DEAE-Sepharose FF column (Pharmacia) and flow through frac-
tions were collected. After 60% saturate ammonium sulfate precipitation,
2 mM GTP or GDP was added and incubated for at least 1 h in buffer D
(50 mM phosphate buffer, pH 7.0, 1 mM 2-mercaptoethanol, 10% glycerol,
2 mM GTP or GDP) on ice. The samples were applied to HiPrep Sephacryl
S-200 HR FPLC column (Pharmacia) equilibrated with buffer D, and
peak fractions containing Ran proteins were pooled. GTP- and GDP-form
of Ran were further separated on Fractogel EMDSO
 
3
 
2
 
650 (s) column
(Merck) with linear gradient of buffer D containing 50 mM phosphate to
500 mM phosphate. GDP-bound form of Ran was eluted between 200 and
250 mM phosphate. GTP-bound form was eluted between 350 and 400
 
mM phosphate. The purified GTP- or GDP-form of Ran was then de-
salted with PD10 column (Pharmacia) equilibrated with transport buffer
(see below), concentrated with centricon 30 (Amicon), and then frozen in
small aliquots.
The guanine nucleotides bound to purified Ran were determined by
FPLC (Pharmacia) after denaturation. The Ran preparations were heated
at 95
 
8
 
C for 2 min. After filtration, the solutions were applied to a monoQ
HR5/5 (Pharmacia) column and then the guanine nucleotides were eluted
with a linear gradient from 10 mM potassium phosphate buffer, pH 8.0, to
50 mM potassium phosphate buffer, pH 8.0, containing 250 mM NaCl. Nu-
cleotides were detected at 254 nm and quantified against a standard GDP/
GTP solution. The bound nucleotides were found to be virtually 100%
GDP for the GDP-bound preparations and 95% GTP for the GTP-bound
preparations.
All GST-fused deletion mutants of human Ran were prepared using
PCR with appropriate oligonucleotides. The PCR product was inserted
into the BamHI/EcoRI site of pGEX-2T vector. For the production of the
GST-fused COOH-terminal domain of Ran, the synthesized oligonucle-
otide, corresponding to the COOH-terminal region of human Ran,
TALPDEDDDL, was inserted into the BamHI/EcoRI site of pGEX-2T
vector (Pharmacia). These resultant plasmids were sequenced to confirm
the fidelity of the region, which had been amplified by PCR and in-frame
ligation of the fused region. Recombinant GST-fused proteins were ex-
pressed by incubation with 1 mM IPTG for 6 h at 37
 
8
 
C in 
 
E
 
.
 
 coli
 
 strain
BL21(DE3). The purification of the GST-fused COOH-terminal domain of
Ran with glutathioneÐSepharose was performed as described for importin 
 
b
 
.
The protein was then dialyzed against 20 mM Hepes, pH 7.3, 110 mM po-
tassium acetate, and 2 mM DTT. 
 Mouse RanBP1 was expressed as GST fusion protein. A fragment
which is encoding the entire amino acid sequence of this protein was am-
plified from mouse Ehrlich ascites tumor cell cDNA by PCR using syn-
thetic oligonucleotides (5
 
9
 
-CCTACGGATCCATGGCGGCCGCCAAGG-
ACA-3
 
9 
 
and 5
 
9
 
-CCACTGAATTCTCATTGTTTCTCCTCAGAC-3
 
9
 
) and
cloned into the BamH1-EcoRI sites of pGEX-2T, to produce an in-frame
fusion with GST. Expression in BL21(DE3), lysis of bacteria, and purifica-
tion of the fusion protein with glutathioneÐSepharose were performed as
described for importin 
 
b
 
. The GST portion of chimeras was cleaved off by
a 2-h incubation at room temperature with 1 NIH U of thrombin (Sigma)
per 100 
 
m
 
g of chimeras. GST and thrombin were separated from recombi-
nant protein on a MonoQ column (Pharmacia Biotech) at flow rate of 0.5
ml/min with a linear gradient from 0.025 to 1.0 M NaCl in 20 mM Hepes,
pH 7.3, 2 mM DTT, and 1 
 
m
 
g/ml each of aprotinin, leupeptin, and pepsta-
tin. Free RanBP1 protein was dialyzed against 20 mM Hepes, pH 7.3, 110
mM potassium acetate, 2 mM DTT, and 1 
 
m
 
g/ml each of aprotinin, leu-
peptin, and pepstatin. 
 
Preparation of Ehrlich Ascites Tumor Cells 
Cytosolic Extract 
 
Cytosolic extract was prepared from Ehrlich ascites tumor cells as de-
scribed previously (Imamoto et al., 1995). 
 
Gel Electrophoresis and Immunoblotting
 
One-dimensional SDS-PAGE was based on the method of Laemmli
(1970) and the gels were stained with Coomassie brilliant blue. For immu-
noblotting, after electrophoresis, proteins were electrophoretically trans-
ferred from gels to nitrocellulose sheets. After blocking with 3% skim
milk in PBS, the sheets were then incubated with the first antibody fol-
lowed by alkaline phosphatase-conjugated anti-mouse or anti-rabbit IgG
(Bio-Rad).
 
Immunofluorescence
 
BHK cells, plated on coverslips, were washed twice in PBS and fixed with
3.7% formaldehyde in PBS (at room temperature for 20 min) followed by
permeabilization with 0.5% Triton X-100 in PBS (at room temperature
for 5 min). After blocking with 3% skim milk in PBS, the cells were incu-
bated with ARAN1 (3 
 
m
 
g/ml) or affinity-purified rabbit anti-Ran polyclonal
antibodies (3 
 
m
 
g/ml) overnight at 4
 
8
 
C and detected with Cy3-conjugated
goat antiÐmouse IgG (Amersham) or FITC-conjugated goat antiÐrabbit
IgG (Tago). The samples were examined using a Zeiss Axiophot fluores-
cent microscope (Carl Zeiss).  
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Immunoprecipitation Using Recombinant Proteins
 
50 pmol of Ran (GTP-bound or GDP-bound) and/or 50 pmol of importin
 
b
 
 were incubated with 50 pmol of ARAN1 in total 300 
 
m
 
l of transport
buffer (TB: 20 mM Hepes, pH 7.3, 100 mM potassium acetate, 2 mM mag-
nesium acetate, 5 mM sodium acetate, 1 mM glycoletherdiaminetetraace-
tic acid [EGTA], 2 mM DTT, and 1 
 
m
 
g/ml each of aprotinin, leupeptin,
and pepstatin) for 1 h at 4
 
8
 
C. Protein AÐbound agarose beads (Calbio-
chem-Novabiochem) were then added and the mixture was incubated for
1 h at 4
 
8
 
C. The beads were collected by centrifugation and washed five
times with TB. The bound fraction and unbound fraction were analyzed
by SDS-PAGE and immunoblotting.
150 pmol of transportin or hGFP-CAS and 150 pmol of Ran-GTP were
incubated with 150 pmol of ARAN1 in the presence or absence of 150
pmol of importin 
 
a
 
 in TB for 1 h at 4
 
8
 
C. The proteins which bound to
ARAN1 were then analyzed using the same procedure as above. 
 
Immunoprecipitation Using Cytosolic Extract
 
To preclear the extract, anti-mouse IgG-conjugated agarose beads (Amer-
ican Qualex) were added to the Ehrlich ascetics tumor cell cytosolic ex-
tract and rotated for 1 h at 4
 
8
 
C. The beads were then removed by centrifu-
gation. 300 pmol of ARAN1 and 300 pmol of Q69L Ran-GTP was added
to 200 
 
m
 
l of the precleared cytosolic extract followed by 1 h of incubation
at 4
 
8
 
C. 15 
 
m
 
l of protein AÐagarose beads were then added to the mixture,
which was then incubated for 1 h. After washing five times with TB, the
proteins bound to the protein AÐconjugated agarose beads were resus-
pended in SDS-PAGE sample buffer containing DTT and analyzed by
immunoblotting using antibodies indicated in the figure legend.
 
Solution Binding Assay 
 
Solution binding assays were performed in TB. 50 pmol of GST-importin
 
b 
 
and 50 pmol of Ran-GTP was incubated with 10 
 
m
 
l of a packed volume
of glutathioneÐSepharose for 1 h at 4
 
8
 
C. After washing the beads twice
with TB, 250 pmol or 2,500 pmol of ARAN1 was added to the mixture fol-
lowed by a 30-min incubation, 50 pmol of RanBP1 was then added and the
mixture incubated for an additional 30 min at 4
 
8
 
C. The beads were washed
with TB and proteins bound to the beads were resuspended in SDS-
PAGE sample buffer containing DTT and analyzed by SDS-PAGE.
50 pmol of GSTÐimportin 
 
b
 
, 50 pmol of Ran-GDP, and 250 pmol of
ARAN1 was incubated with 10 
 
m
 
l of a packed volume of glutathioneÐ
Sepharose for 1 h at 4
 
8
 
C. After washing the beads twice with TB, 50 pmol
of RanBP1 was added to the beads and the mixture incubated for 1 h. For
a control, 50 pmol of GSTÐimportin 
 
b
 
, Ran-GDP, and RanBP1 were incu-
bated with glutathioneÐSepharose for 1 h. The beads were then washed
with TB and proteins bound to the beads were resuspended in SDS-
PAGE sample buffer containing DTT, and then analyzed by SDS-PAGE.
 
Preparation of Fluorescein-labeled NLS-containing 
Transport Substrates
 
BSA was fluorescein-labeled and then chemically conjugated to the syn-
thetic peptides which contained the amino acid sequence of SV-40 large
T-antigen NLS (CYGGPKKKRKVEDP), for the transport substrates
termed FITCÐT-BSA, as described previously (Tachibana et al., 1994). 
 
Microinjection 
 
BHK cells were grown on coverslips. Microinjection of proteins was per-
formed as described previously (Yoneda et al., 1987). After incubation for
the indicated time in each figure at 37
 
8
 
C, the cells were fixed with 3.7%
formaldehyde in PBS. The injected fluorescently labeled proteins were
detected by fluorescent microscopy (model Axiophot 2; Carl Zeiss).
 
Results
 
A Monoclonal Antibody Specific for Ran 
 
To study the functional domain(s) of Ran, monoclonal an-
tibodies were produced against recombinant human Ran.
The screening of the monoclonal antibodies was based on
two criteria: (a) that they react with only Ran protein in
immunoblotting; and (b) that they show the same staining
pattern with polyclonal anti-Ran antibodies in immunoflu-
orescence microscopy. Through this screening procedure,
we isolated only one clone, designated ARAN1, for fur-
ther characterization. ARAN1 was typed using a mouse
monoclonal antibody isotyping kit as an immunoglobulin
kappa G2b. On an immunoblot, ARAN1 detected recom-
binant human Ran and specifically reacted with a single
25-kD band in cell extracts from mouse Ehrlich ascites tu-
mor cells, BHK21 cells, human embryonic lung (HEL)
cells (Fig. 1 A), Madin-Darby bovine kidney-derived epi-
thelial cells (MDBK), and 
 
Xenopus laevis
 
 oocytes (data
not shown), which was also detected by affinity-purified rab-
bit anti-Ran polyclonal antibodies. Furthermore, ARAN1
recognized a single spot by immunoblotting analysis of HeLa
total cell extracts after two-dimensional electrophoresis,
which was also detected with the anti-Ran polyclonal anti-
bodies (data not shown). Immunofluorescent image with
ARAN1 in BHK cells showed the same typical staining
pattern as that with the anti-Ran polyclonal antibodies
(Fig. 1 B). From these findings, it was concluded that the
monoclonal antibody ARAN1 specifically binds to Ran. 
 
ARAN1 Recognizes an Epitope at the COOH-terminal 
Domain of Ran 
 
To determine the specific epitope recognized by ARAN1,
we prepared a series of truncated forms of recombinant
Ran fused with GST (Fig. 2 A) and analyzed the interac-
tion of these with ARAN1 by immunoblotting. Although
anti-GST polyclonal antibodies showed that all of the Ran
mutants were appropriately expressed and transferred to
Figure 1. Anti-Ran monoclonal antibody,
ARAN1, mono-specifically recognizes Ran
molecule. (A) Cytosolic extract from mouse
Ehrlich ascites tumor cells (lanes 1 and 2),
and total extracts of HEL cells (lane 3) and
BHK21 cells (lane 4) were electrophoresed
on 12.5% polyacrylamide gels, transferred to
nitrocellulose, and then probed with anti-Ran
polyclonal antibodies (lane 1) and ARAN1
(lanes 2, 3, and 4). (B) BHK21 cells were dou-
ble stained with ARAN1 and rabbit anti-Ran
polyclonal antibodies. ARAN1 and rabbit
anti-Ran polyclonal antibodies were detected with goat Cy3-conjugated antiÐmouse IgG and goat FITC-con-
jugated antiÐrabbit IgG, respectively. PhaseÐcontrast microscopy is also shown. 
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nitrocellulose (Fig. 2 B), ARAN1 recognized only the full-
length of GST-Ran. Removal of the COOH-terminal seven
amino acids (210Ð216) of Ran completely abolished the re-
activity with ARAN1 in immunoblotting, suggesting that
the COOH-terminal domain, which consists of seven amino
acid residues in Ran, represents the epitope for ARAN1.
To confirm this, we prepared the 10-mer peptide of the
COOH-terminal domain, 207Ð216, of Ran fused to GST
(Fig. 3 A). As shown in Fig. 3, B and C, ARAN1 clearly
reacted with the residues between 207 and 216 of human
Ran not only in immunoblotting but also in a solution bind-
ing assay. From these findings, it was concluded that the
epitope of ARAN1 is located in the COOH-terminal portion
of Ran, which is highly negatively charged (
 
2
 
DEDDDL)
and conserved among species (Fig. 3 D).
 
ARAN1 Binds to the RanÐImportin 
 
b
 
 Complex But Not 
the Ran Molecule Alone in Solution Binding Assay
 
It is known that the stable Ran-GTPÐimportin 
 
b 
 
complex
causes the inhibition of GTP hydrolysis on Ran stimulated
by RanGAP1. In contrast, Ran-GDP shows a much lower
affinity to importin 
 
b 
 
than Ran-GTP. To determine which
form of Ran is recognized by ARAN1 in solution, immu-
noprecipitation analysis of ARAN1 using recombinant
proteins was performed. Purified recombinant human
Ran-GTP or Ran-GDP was incubated with ARAN1 in the
presence or absence of importin 
 
b 
 
followed by the precipi-
tation with protein AÐconjugated agarose beads. The re-
sults showed that, whereas ARAN1 precipitated neither
Ran-GTP nor Ran-GDP alone, it reacted with both Ran-
GTP and Ran-GDP only in the presence of importin b and
precipitated both Ran and importin b. To clearly confirm
that ARAN1 canÕt recognize Ran molecule alone, precipi-
tated proteins were analyzed by immunoblotting with anti-
Ran polyclonal antibodies (Fig. 4 A). The molar ratio of
the Ran and importin b precipitated with ARAN1 was es-
timated to be z1:1 (data not shown). Since ARAN1 did
Figure 2. Mapping of the ARAN1 binding domain in the Ran
molecule. (A) Schematic presentation of Ran and a series of
truncated forms of Ran, which were expressed in E. coli as re-
combinant GST fusion proteins. Numbers at left, amino acid po-
sitions of the Ran sequence. A full length of human Ran consists
of 216 amino acid residues. (B) Immunoblotting analysis of full
and mutant Ran proteins using ARAN1 and rabbit anti-GST
polyclonal antibodies. E. coli was harvested after 6 h of induction
with IPTG and lysed in SDS-PAGE sample buffer. Samples were
electrophoresed on 12.5% polyacrylamide gels, transferred to ni-
trocellulose, and then probed with the ARAN1 and anti-GST
polyclonal antibodies. Right, a loading control stained with Coo-
massie brilliant blue.
Figure 3. ARAN1 recognizes an epitope located within 10 amino
acid residues of the COOH terminus of Ran. (A) Schematic
drawing of the recombinant fusion protein of the COOH-termi-
nal tail fragment of Ran expressed in E. coli. (B) Immunoblotting
analysis of the E. coli extract which expresses the GST fused Ran
COOH-terminal tail, 207Ð216 with ARAN1 (lane 1). Lane 2
shows negative control without ARAN1. The right panel shows
an SDS-PAGE profile of E. coli extract expressing GST-fused
COOH-terminal tail fragment of Ran, applied in the same
amount as was used for immunoblotting. (C) Recombinant GST-
fused COOH-terminal portion (207Ð216) of Ran (lane 1) or GST
(lane 2) is incubated with ARAN1 and protein AÐbound agarose
beads for 1 h. The beads were then washed and the bound
proteins were analyzed by SDS-PAGE followed by Coomassie
brilliant blue staining. (D) Amino acid comparison of the COOH-
terminal domain of Ran in human, mouse, C. elegans and S. cere-
visiae. The COOH-terminal domain of human RhoA is also
shown. Negatively charged residues are shown in boldface.The Journal of Cell Biology, Volume 144, 1999 650
not bind to importin b directly in this assay, these results
indicate that ARAN1 reacts only with Ran when bound to
importin b, and suggest that Ran changes conformation
when bound to importin b which, in turn, exposes its
COOH-terminal portion. 
ARAN1 Also Binds to the RanÐTransportin Complex 
and the RanÐCASÐImportin a Complex
It is well known that Ran interacts with some import and
export receptors, e.g., transportin, CAS, and CRM1, which
are members of the superfamily of Ran-GTP-binding pro-
tein/importin b (Kutay et al., 1997; Grlich et al., 1997;
Fornerod et al., 1997a). Tranportin forms a complex with
Ran-GTP and CAS simultaneously binds to both Ran-
GTP and importin a (Kutay et al., 1997). Judging from the
conservation of the Ran-binding domain in this family, it is
likely that the COOH-terminal tail of Ran may also be ex-
posed as the result of the interaction with these molecules.
To confirm this, we performed the solution binding assay
with different importin bÐrelated transport factors, trans-
portin, and CAS. The results clearly showed that ARAN1
binds to both Ran-GTP/transportin complex and Ran-
GTPÐCASÐimportin  a complex (Fig. 4 B), suggesting that
importin bÐrelated transport factors might induce a gen-
eral conformational change in Ran through their interac-
tion. In the case of CAS, it should be noted that a slight
recognition of a complex between CAS and Ran-GTP by
ARAN1 can also be observed (Fig. 4 B). This suggests that
CAS directly binds to Ran-GTP in the absence of importin
a, although the affinity is very low. 
ARAN1 Suppresses the Ternary Complex Formation of 
Ran, Importin b, and RanBP1 in a Solution 
Binding Assay
Both Ran-GTP and Ran-GDP form a ternary complex
with RanBP1 and importin b in a solution binding assay.
Although it has been assumed that RanBP1 plays a role in
the dissociation of the Ran-GTPÐimportin b complex, the
biological significance of the ternary complex has not yet
been established. The RanBP1ÐRan-GDPÐimportin b com-
plex has been proposed to play a role in nuclear protein im-
port as a ternary complex (Chi et al., 1997), although it has
not yet demonstrated how the complex functions in the nu-
clear protein import. We therefore examined the effects of
ARAN1 on the interaction of RanBP1 with both Ran-GTPÐ
importin b and Ran-GDPÐimportin b complexes in the solu-
tion binding assay. In the absence of ARAN1, GST-tagged
importin b efficiently precipitated both Ran-GTP and Ran-
GDP together with RanBP1 in a molar ratio of 1:1 (Fig. 5, A
and B, lane 1). In contrast, in the presence of ARAN1, the
amount of RanBP1 precipitated with GST-tagged importin
b apparently decreased, although the Ran was efficiently
precipitated. These results indicate that RanBP1 is not able
to interact with the Ran-GTPÐimportin b and Ran-GDPÐ
importin b complexes, when bound to ARAN1. That is, the
binding of ARAN1 to the RanÐimportin b complex sup-
presses the ternary complex formation of both RanBP1Ð
Ran-GTPÐimportin b and RanBP1ÐRan-GDPÐimportin b
in solution. 
RanÐImportin bÐrelated Transport Factor Complex Is 
Exported from the Nucleus to the Cytoplasm
As described above, it has been proposed that the Ran-GTPÐ
importin b complex and Ran-GTPÐimportin bÐrelated trans-
port factor (such as transportin and CAS) complex are
formed in the nucleus and exported to the cytoplasm. To
determine whether these complexes are actually formed in
the nucleus and migrate to the cytoplasm as a single entity
in living cells, ARAN1, which binds to only the Ran com-
plexed with importin b and importin bÐrelated transport
factors in solution, was injected into the cytoplasm or nucleus
of cultured BHK cells. It was found that nuclear-injected
ARAN1 was efficiently exported to the cytoplasm within
30 min of incubation (Fig. 6 A), whereas control mouse
IgG was retained in the injected nucleus (data not shown).
Since due to its size (Mr 5 160,000), mouse IgG cannot
passively traverse the nuclear envelope (Wen et al., 1995),
these results indicate that ARAN1 migrates to the cyto-
plasm in a piggyback fashion. These findings suggest that it
is most likely that ARAN1 binds to the Ran-GTP com-
Figure 4. ARAN1 recognizes the RanÐimportin bÐrelated trans-
port factors complex but not the Ran molecule alone in solution.
(A) Recombinant Ran-GTP, Ran-GDP, and/or importin b were
incubated with ARAN1 for 1 h at 48C and protein AÐagarose was
then added. After a 1-h incubation, the bound proteins were ana-
lyzed by SDS-PAGE followed by Coomassie blue staining for
importin b and by immunoblotting for Ran using rabbit anti-Ran
polyclonal antibodies. Top and bottom panels show the bound
and unbound fractions, respectively. ARAN1 failed to precipi-
tate Ran-GTP, Ran-GDP, and importin b alone, and precipitated
only the Ran-GTPÐimportin b complex and Ran-GDPÐimportin
b complex. (B) ARAN1 also recognizes the Ran/transportin
complex and Ran/CASÐimportin a complex. Recombinant trans-
portin or CAS and importin b were incubated with Ran-GTP and
ARAN1, then precipitated by protein AÐagarose and analyzed
by SDS-PAGE.Hieda et al. Recycling of Ran and Nuclear Protein Import 651
plexed with importin bÐrelated transport factors in the nu-
cleus, in which Ran would exist as the GTP-bound form,
and is transported to the cytoplasm as a complex with them.
That is, these results suggest that the Ran-GTPÐimportin
bÐrelated transport factor complex moves to the cyto-
plasm as a single entity without dissociation. On the other
hand, cytoplasmically injected ARAN1 remained in the cy-
toplasm even after 3 h of incubation (data not shown).
To determine whether ARAN1 actually recognizes the
Ran-GTPÐimportin bÐrelated transport factor complex in
a crude cell extract, we performed immunoprecipitation
analysis with mouse Ehrlich ascites tumor cell cytosolic ex-
tract in the presence of Q69L Ran-GTP, which should sta-
bilize the complexes of importin bÐrelated transport fac-
tors and Ran-GTP in the crude lysate. As shown in Fig. 6
B, importin b, CAS, and transportin were coprecipitated
with the Ran from the cell lysate by ARAN1. This result
supports the view that nuclear-injected ARAN1 binds to
Ran-GTPÐimportin bÐrelated factors and is exported from
the nucleus to the cytoplasm in vivo. 
ARAN1 Affects the Distribution of Endogenous Ran
Ran is localized predominantly in the nucleus. If Ran con-
tinuously shuttles between two compartments, the nucleus
and cytoplasm, and the binding of RanBP1 to the Ran-
GTPÐimportin b complex in the cytoplasm is required for
the recycling of Ran to the nucleus, ARAN1 would be ex-
pected to affect the distribution of Ran. To examine this
hypothesis, ARAN1 was introduced into the cell and the dis-
tribution of endogenous Ran was observed. As shown in Fig.
6, 30 min after injection into either the nucleus or the cyto-
plasm, injected ARAN1 localized in the cytoplasm. 30 min
after injection of ARAN1 into either the nucleus or the cyto-
plasm, the subcellular localization of endogenous Ran be-
came apparently dominant in the cytoplasm of the ARAN1-
Figure 5. ARAN1 prevents the formation of Ran/RanBP1Ð
importin  b complex. (A) ARAN1 was added to the immobilized
importin bÐRan-GTP complex and incubated for 30 min. RanBP1
was then added to the mixture. After 30 min of incubation, the
proteins bound to importin b were precipitated and analyzed
by SDS-PAGE followed by Coomassie brilliant blue staining. (B)
GST-tagged importin b was mixed with the Ran-GDP and
ARAN1  and then incubated with glutathioneÐSepharose beads
for 1 h. After washing the beads, RanBP1 was added the mixture
and incubated for 1 h. The proteins bound to importin b were
precipitated and analyzed by SDS-PAGE followed by Coomassie
brilliant blue staining.
Figure 6. ARAN1 is exported from the nucleus to the cytoplasm.
ARAN1 (5 mg/ml) was injected into the cytoplasm (top) or nu-
cleus (bottom) of BHK21 cells with FITC-BSA. After incubation
at 378C for 30 min, cells were fixed and stained with Cy3-conju-
gated goat antiÐmouse IgG antibodies (right). The localization of
FITC-BSA shows the injected site in the cells. (B) ARAN1 rec-
ognizes the RanÐimportin b complex in Ehrlich ascites tumor cell
cytosolic extract. ARAN1 was added (lanes 1 and 3) or not (lanes
2 and 4) into the cytosolic extract and incubated for 1 h in the
presence of Q69L Ran-GTP. The proteins which were bound to
ARAN1 were precipitated with protein AÐagarose beads and an-
alyzed by immunoblotting with rabbit anti-Ran polyclonal anti-
bodies (lanes 1 and 2), rabbit antiÐimportin b polyclonal antibod-
ies (lanes 3 and 4), mouse anti-transportin monoclonal antibody,
and mouse anti-CAS monoclonal antibody (lanes 5 and 6, respec-
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injected cells, whereas control mouse IgG had no effect on
this distribution (Fig. 7 A for cytoplasmic injection and data
not shown for nuclear injection). The relocalization of Ran
was caused irrespective of the injection sites of ARAN1. 
ARAN1 Inhibits the Nuclear Import of Proteins 
Containing the Classical NLS 
Lastly, we examined the effect of ARAN1 on the nuclear
protein import in living cells. For this, ARAN1 or control
mouse IgG was injected into nucleus or cytoplasm before
the cytoplasmic injection of FITC-labeled BSA conjugated
with the NLS peptide of SV-40 T antigen (FITCÐT-BSA).
In both cases, in which ARAN1 was injected into the cyto-
plasm or the nucleus, the nuclear import of FITCÐT-BSA,
which was injected afterwards was clearly inhibited (Fig. 7
B for cytoplasmic injection and data not shown for nuclear
injection). In both cases, the injected ARAN1 was con-
firmed to be localized in the cytoplasm as expected from
the results of Fig. 6 (data not shown). In contrast, the si-
multaneous cytoplasmic injection of ARAN1 with FITCÐ
T-BSA failed to inhibit the nuclear import of the FITCÐ
T-BSA (data not shown). These results suggest that the
injected ARAN1 interrupts the Ran cycle in the cytoplasm
probably by preventing RanBP1 from interacting with the
RanÐimportin b complex, which causes an abnormal dis-
tribution of Ran and further the suppression of nuclear
protein import.
Discussion 
The COOH-terminal Acidic Domain of Ran Is Exposed 
to the Molecular Surface as the Result of Its Interaction 
with Importin b or Importin b Families
In this study we obtained a monoclonal anti-Ran antibody,
ARAN1, which recognizes mono-specific Ran as confirmed
by immunoblotting of total cell extract and immunofluores-
cent analysis of cultured cells. An epitope of ARAN1 was
found to lie in the acidic COOH-terminal domain of Ran. A
solution binding assay revealed that ARAN1 interacts only
with Ran, when it is complexed with importin b, transpor-
tin, or CASÐimportin a but not Ran alone. These results in-
dicate that the COOH-terminal domain of Ran is exposed
to the molecular surface probably as the result of a confor-
mational change only when importin bÐrelated transport
factors bind to Ran. 
Figure 7. ARAN1 induces the intracellular localization rearrange-
ment of Ran and inhibits the basic type NLS-dependent nuclear
protein import. (A) ARAN1 (bottom) or control mouse IgG (top,
both 50 mg/ml) was injected into the cytoplasm of the cultured
BHK21 cells and incubated at 378C for 30 min. The cells were fixed
and probed with rabbit anti-Ran antibodies at 48C overnight, and
then stained with Cy3-conjugated goat antiÐrabbit antibodies. In-
jected ARAN1 and control mouse IgG was detected with FITC-
conjugated goat antiÐmouse IgG antibodies. PhaseÐcontrast mi-
croscopy is shown in the right panels. (B) ARAN1 or control
mouse IgG (50 mg/ml) was injected into the cytoplasm of cultured
BHK21. After a 30-min incubation at 378C, FITC-labeled T-BSA
was injected into the cytoplasm of the same cells. After incubation
at 378C for 20 min, the cells were fixed and observed by fluorescent
microscopy. Injected IgG was detected with Cy3-labeled anti-
mouse IgG.Hieda et al. Recycling of Ran and Nuclear Protein Import 653
Although ARAN1 recognizes only Ran complexed with
importin b or its related transport factors in solution, it
shows the same immunofluorescence pattern as a poly-
clonal anti-Ran antibodies (Fig. 1). Since it was previously
reported that importin b is located not only in the cyto-
plasm but also within the nucleus (Kose et al., 1997), it is
likely that the apparent nucleoplasmic staining by ARAN1
means the complex formation of Ran with importin b and
importin bÐrelated transport factors in the nucleus. Alter-
natively, this can be explained by a similar degree of Ran
denaturation during cell fixation as in immunoblotting. 
 It was found that ARAN1 binds to Ran-GDPÐimportin
b  complex as well as Ran-GTPÐimportin b complex,
whereas it is known that importin b binds to Ran-GDP with
much lower affinity than to Ran-GTP. Chi et al. (1996)
demonstrated that the addition of RanBP1 with Ran-GDP
increased the affinity of Ran-GDP for importin b. By anal-
ogy, it is speculated that ARAN1 may stabilize the interac-
tion of Ran-GDP with importin b like RanBP1. In both
cases, whereas ARAN 1 cannot reach the COOH-terminal
domain of Ran-GTP or Ran-GDP alone, the interaction of
Ran with importin b appears to induce a conformational
change of Ran so that ARAN1 is able to recognize the
epitope domain. Richards et al. (1995) demonstrated that
a polyclonal antibody against a peptide corresponding to
residues 196Ð207 of Ran, which is adjacent to the acidic
211DEDDDL-COOH216 domain, preferentially recognizes
the GTP-bound form of Ran. They therefore proposed
that the COOH-terminal domain is structurally flexible and
undergoes a nucleotide-dependent conformational change,
which is not inconsistent with the results herein.
Due to the characteristic amino acid sequences and con-
formational flexibility, it is likely that the COOH-terminal
domain has some functions. Richards et al. (1995) also
proposed from their biochemical analysis using DDE-Ran
that the DEDDDL sequence stabilizes the GDP form of
Ran, possibly by folding into the guanine nucleotide binding
pocket and mimicking the negative charge on the g-phos-
phate of GTP. In addition, it was suggested that the COOH
terminus of Ran is implicated in the regulation of interac-
tion between Ran and RanBP1 (Richards et al., 1995).
Consistent with their suggestion, we showed that the bind-
ing of ARAN1 to the COOH-terminal tail suppresses the
interaction of RanBP1 with the RanÐimportin b complex.
Although DDE-Ran is able to bind to RanBP1, its affinity
to RanBP1 is lower than wild-type Ran (Richards et al.,
1995). Therefore, we speculate that exposure of the COOH-
terminal tail may increase the accessibility of RanBP1 not
only to the RanÐimportin b complex but also to the RanÐ
importin bÐrelated transport factors. 
A similar sequence in importin b ( 335DENDDDW342)
with the COOH-terminal domain of Ran is immediately
adjacent to sequences required for binding Ran-GDP/
RanBP1, but not Ran-GTP (Chi et al., 1997). They pro-
posed that this sequence in importin b substitutes for the
COOH-terminal Ran sequence in the nucleotide binding
pocket of Ran when GDP is bound and that this rear-
rangement would expose the COOH terminus of Ran for
binding to RanBP1, stabilizing the trimeric complex. Their
proposal is consistent with our result that the COOH-ter-
minal tail of Ran-GDP was also exposed by the binding of
importin b. 
The Export of RanÐImportin bÐrelated Transport 
Factor Complexes from the Nucleus 
Although it has been proposed that the RanÐimportin
bÐrelated transport factor complexes form in the nucleus,
are exported to the cytoplasm, and then dissociate in order
to recycle (Bischoff and Grlich, 1997; Izaurralde et al.,
1997), this proposal has not been experimentally verified
in vivo. Recently, Izaurralde et al. (1997) showed that the
depletion of nuclear Ran-GTP inhibits the export of im-
portin a and b, transportin and NES-containing proteins
in Xenopus laevis oocyte, suggesting that nuclear Ran-
GTP is required for the export of importin a and b, trans-
portin, and NES-containing proteins from the nucleus.
However, their results do not necessarily mean that the
RanÐimportin bÐrelated transport factor complexes are
translocated from the nucleus to the cytoplasm as a com-
plex. Thus, in regard to the dynamic behavior of Ran
through the nuclear envelope, little concrete experimental
data exist. In this study, we found that a monoclonal anti-
Ran antibody ARAN1 failed to inhibit the export of Ran
from the nucleus and inhibited reimport into the nucleus,
and that nuclearly injected ARAN1 was efficiently ex-
ported from the nucleus. Our results indicate that the
RanÐimportin bÐrelated transport factor complexes effi-
ciently migrate from the nucleus to the cytoplasm as a com-
plex in living cells, even when complexed with ARAN1. Al-
though it can not be excluded that the nuclear export of
ARAN1 injected into the nucleus could be due to complex
formation with Ran-GDPÐimportin bÐrelated factors rather
than Ran-GTPÐimportin bÐrelated factors, the current model
of a steep Ran-GTP gradient across the nuclear membrane
(see introduction) and the immunoprecipitation experi-
ments with ARAN1 in the presence of Q69L Ran-GTP
(Fig. 6 B) support that ARAN1 is exported from the nu-
cleus as a complex with Ran-GTP and importin bÐrelated
factors. 
The Role of RanBP1 in the Recycling of Ran
After the translocation of the RanÐimportin b complex
into the cytoplasm, it is predicted that the complex is disas-
sembled for the next round of nuclear import and the recy-
cling of Ran. The Ran-GTPÐimportin b complex is kineti-
cally very stable (the dissociation constant is z1 nM, when
nucleotide exchange and GTP hydrolysis are blocked)
(Grlich et al., 1996; Izaurralde et al., 1997). Injected
ARAN1 induced the relocalization of endogenous Ran in
living cells. That is, endogenous Ran was found predomi-
nantly in the cytoplasm within 30 min after injection (Fig.
7). Since the injected ARAN1 was also localized in the cy-
toplasm, irrespective of the injection site (Fig. 6), it is con-
cluded that ARAN1 prevented the event(s) from occur-
ring in the cytoplasm but not in the nucleus. Our in vitro
biochemical experiments (Figs. 4 and 5) strongly suggest
that the injected ARAN1 efficiently interacts with the
RanÐimportin b complex in the nucleus or the cytoplasm
and prevents the binding of RanBP1 to the RanÐimportin
b complex in the cytoplasm. Furthermore, it was found
that the COOH-terminal tail of Ran is also exposed via in-
teraction with other importin b family molecules. There-
fore, we conceive that Ran probably remains in the cyto-
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factors due to the inhibition by ARAN1 on the binding of
RanBP1 to RanÐimportin b or its related transport factor
complexes in the cytoplasm, although we did not examine
in this study that ARAN1 actually inhibits the binding of
RanBP1 to the complex of Ran with importin bÐrelated
transport factors other than importin b. At least part of
our conclusion is consistent with the recent biochemical
analysis by Bischoff and Grlich (1997). They showed that
the importin a  and RanBP1 cooperatively relieved the
GAP resistance of the Ran-GTPÐimportin b complex, sug-
gesting that RanBP1 is critical for the release of Ran-GTP
from importin b. Moreover, in our study, it was found that
ARAN1 competes much better for RanBP1 complexed to
Ran-GDPÐimportin b than to Ran-GTPÐimportin b, which
means that RanBP1 has much higher affinity for Ran-GTPÐ
importin b complex than for Ran-GDPÐimportin b com-
plex. This is consistent with the idea that RanBP1 efficiently
binds to Ran-GTPÐimportin b complex in the cytoplasm
to promote the dissociation of the complex.
RanBP2 contains four Ran-binding domains which are
functionally equivalent to RanBP1 (Lounsbury et al.,
1994; Yokoyama et al., 1995). It is located at the cytoplas-
mic filaments of the NPC (Wu et al., 1995; Yokoyama et al.,
1995) and a fraction of RanGAP which is modified by the
addition of a small ubiquitin-like peptide binds to RanBP2
(Matunis et al., 1996; Mahajan et al., 1997; Saitoh et al.,
1997). Therefore, RanBP2 may play the same role as
RanBP1 in the recycling of Ran, although further experi-
ments will be required to better understand the role(s) of
RanBP2 on the nucleocytoplasmic transport of macromol-
ecules as well as to understand the effect of ARAN1 on
RanBP2.
Nuclear Protein Import and Recycling of Ran and 
Importin b
This study showed that ARAN1, when injected into cul-
tured cells inhibits nuclear protein import mediated by ba-
sic-type classical NLS irrespective of the injection site, i.e.,
nucleoplasm or cytoplasm. It has been recently reported
that RanBP1 is required for nuclear protein import and
RNA export in vivo (Schlenstedt et al., 1995; Richards et al.,
1996) and stimulates the protein import in a permeabilized
cell-free assay (Chi et al., 1996). Furthermore, it has been
shown that the COOH terminus deleted Ran (DDE-Ran)
represents the dominant-negative effect on the nuclear
protein import. In this study, we found that ARAN1 inhib-
its the interaction of RanBP1 (and probably RanBP2)
with the RanÐimportin b complex. There are two possible
explanations for the inhibitory effect of ARAN1 on the
nuclear import of the classical NLS substrates. One possibil-
ity is that ARAN1 may inhibit the interaction of RanBP1 to
Ran-GTPÐimportin  b  complex, which leads to the sup-
pression of the disassembly of the complex. Alternatively,
consistent with the suggestion of Chi et al. (1996) that
RanBP1 promotes nuclear protein import by stabilizing the
interaction of Ran-GDP with importin b, ARAN1 may
block the function of RanBP1 on the interaction of Ran-
GDP with importin b by binding to the Ran-GDPÐimportin
b complex stably and, as a result, affect nuclear protein
import.
Thus, it seems most likely that the inhibition of the func-
tion of RanBP1 (and probably RanBP2) blocks the dis-
assembly of RanÐimportin b complex in the cytoplasm,
which causes the depletion of nuclear Ran, an inhibition in
the recruitment of importin b, and further, the decline of
the recycling of importin a/b to the cytoplasm by the sup-
pression of the dissociation of the nuclear pore-targeting
complex (importin a/b bound to a karyophile) in the nu-
cleus following the depletion of nuclear Ran. It appears
that such an imbalance in the import factors totally inhib-
its the nuclear protein import. Further studies will be nec-
essary in order to understand whether ARAN1 also af-
fects import and export pathways other than the classical
NLS import pathway.
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